These findings support a role for DNMTi in improving antigen presentation, promoting the absorption of tumor antigens by DCs, and cross-presenting antigens to CD8+ T cells, thus initiating T cell recognition and killing of tumor cells. Here, CD8A is linked to neoplasm.